Lexicon Pharmaceuticals Inc (NASDAQ: LXRX) is -40.85% lower on its value in year-to-date trading and has touched a low of $0.97 and a high of $3.73 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The LXRX stock was last observed hovering at around $0.98 in the last trading session, with the day’s loss setting it -0.08%.
Currently trading at $0.90, the stock is -37.83% and -43.16% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 2.84 million and changing -7.20% at the moment leaves the stock -52.00% off its SMA200. LXRX registered -20.61% loss for a year compared to 6-month gain of -48.87%. The firm has a 50-day simple moving average (SMA 50) of $1.6134 and a 200-day simple moving average (SMA200) of $1.8907.
The stock witnessed a -54.98% loss in the last 1 month and extending the period to 3 months gives it a -46.45%, and is -28.74% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 8.86% over the week and 9.21% over the month.
Lexicon Pharmaceuticals Inc (LXRX) has around 285 employees, a market worth around $300.98M and $5.23M in sales. Profit margin for the company is -4109.41%. Distance from 52-week low is -6.73% and -75.74% from its 52-week high. The company has generated returns on investments over the last 12 months (-75.91%).
with sales reaching $7.09M over the same period.The EPS is expected to grow by 14.94% this year, but quarterly earnings will post 874.03% year-over-year. Quarterly sales are estimated to grow 910.29% in year-over-year returns.
Lexicon Pharmaceuticals Inc (LXRX) Top Institutional Holders
184.0 institutions hold shares in Lexicon Pharmaceuticals Inc (LXRX), with institutional investors hold 82.97% of the company’s shares. The shares outstanding are 361.49M, and float is at 304.81M with Short Float at 9.40%. Institutions hold 82.02% of the Float.
The top institutional shareholder in the company is ARTAL GROUP S.A. with over 175.1 million shares valued at $294.17 million. The investor’s holdings represent 71.3555% of the LXRX Shares outstanding. As of 2024-06-30, the second largest holder is FMR LLC with 38.69 million shares valued at $64.99 million to account for 15.7656 of the shares outstanding. The other top investors are BLACKROCK INC. which holds 9.89 million shares representing 4.0304% and valued at over $16.62 million, while BRAIDWELL LP holds 3.3803 of the shares totaling 8.29 million with a market value of $13.94 million.
Lexicon Pharmaceuticals Inc (LXRX) Insider Activity
#####
